APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Exosome Manufacturing Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Exosome Manufacturing Service Market Outlook and Growth Opportunities 2026

Report ID 17413729046 March 2026197 pages

Choose your research edition.

Industry ResearchExosome Manufacturing Service Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Exosome Manufacturing Service Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Exosome Manufacturing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Exosome Manufacturing Service Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Exosome Manufacturing Service Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Exosome Manufacturing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Exosome Manufacturing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Exosome Manufacturing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Exosome Manufacturing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Exosome Manufacturing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Exosome Manufacturing Service market include Guidon (Beijing) Pharmaceutical Technology, Cytoniche, EverZom, Lonza, RoosterBio, SBI, Creative-Biolabs, Esco Aster and EXO Biologics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Exosome Manufacturing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Exosome Manufacturing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Exosome Manufacturing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Exosome Manufacturing Service market.

Exosome Manufacturing Service Segment by Company

Guidon (Beijing) Pharmaceutical Technology

Cytoniche

EverZom

Lonza

RoosterBio

SBI

Creative-Biolabs

Esco Aster

EXO Biologics

Eppendorf

Aethlon Medical

Exosome Manufacturing Service Segment by Type

Human Embryonic Kidney Cell-Derived Exosomes

Bone Marrow Stem Cell-Derived Exosomes

Immature Dendritic Cell-Derived Exosomes

Milk-Derived Exosomes

Red Blood Cell-Derived Exosomes

Others

Exosome Manufacturing Service Segment by Application

Laboratory

Pharmaceutical Companies

Others

Exosome Manufacturing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Exosome Manufacturing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Exosome Manufacturing Service key companies, revenue, market share, and recent developments.

3. To split the Exosome Manufacturing Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Exosome Manufacturing Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Exosome Manufacturing Service significant trends, drivers, influence factors in global and regions.

6. To analyze Exosome Manufacturing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exosome Manufacturing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Exosome Manufacturing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exosome Manufacturing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Exosome Manufacturing Service industry.

Chapter 3: Detailed analysis of Exosome Manufacturing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Exosome Manufacturing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Exosome Manufacturing Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Exosome Manufacturing Service Industry Trends Table 2. Exosome Manufacturing Service Industry Drivers Table 3. Exosome Manufacturing Service Industry Opportunities and Challenges Table 4. Exosome Manufacturing Service Industry Restraints Table 5. Global Exosome Manufacturing Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Exosome Manufacturing Service Revenue Share by Company (2021-2026) Table 7. Global Exosome Manufacturing Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Exosome Manufacturing Service Key Company Manufacturing Base & Headquarters Table 9. Global Exosome Manufacturing Service Company, Product Type & Application Table 10. Global Exosome Manufacturing Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Exosome Manufacturing Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Human Embryonic Kidney Cell-Derived Exosomes Table 15. Significant Companies of Bone Marrow Stem Cell-Derived Exosomes Table 16. Significant Companies of Immature Dendritic Cell-Derived Exosomes Table 17. Significant Companies of Milk-Derived Exosomes Table 18. Significant Companies of Red Blood Cell-Derived Exosomes Table 19. Significant Companies of Others Table 20. Global Exosome Manufacturing Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Exosome Manufacturing Service Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Exosome Manufacturing Service Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Exosome Manufacturing Service Sales Value Share by Type (2021-2026) Table 24. Global Exosome Manufacturing Service Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Laboratory Table 26. Significant Companies of Pharmaceutical Companies Table 27. Significant Companies of Others Table 28. Global Exosome Manufacturing Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Exosome Manufacturing Service Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Exosome Manufacturing Service Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Exosome Manufacturing Service Sales Value Share by Application (2021-2026) Table 32. Global Exosome Manufacturing Service Sales Value Share by Application (2027-2032) Table 33. Global Exosome Manufacturing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Exosome Manufacturing Service Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Exosome Manufacturing Service Sales Value Share by Region (2021-2026) Table 36. Global Exosome Manufacturing Service Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Exosome Manufacturing Service Sales Value Share by Region (2027-2032) Table 38. Global Exosome Manufacturing Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Exosome Manufacturing Service Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Exosome Manufacturing Service Sales Value Market Share by Country (2021-2026) Table 41. Global Exosome Manufacturing Service Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Exosome Manufacturing Service Sales Value Market Share by Country (2027-2032) Table 43. Guidon (Beijing) Pharmaceutical Technology Company Information Table 44. Guidon (Beijing) Pharmaceutical Technology Business Overview Table 45. Guidon (Beijing) Pharmaceutical Technology Exosome Manufacturing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Guidon (Beijing) Pharmaceutical Technology Exosome Manufacturing Service Product Portfolio Table 47. Guidon (Beijing) Pharmaceutical Technology Recent Development Table 48. Cytoniche Company Information Table 49. Cytoniche Business Overview Table 50. Cytoniche Exosome Manufacturing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Cytoniche Exosome Manufacturing Service Product Portfolio Table 52. Cytoniche Recent Development Table 53. EverZom Company Information Table 54. EverZom Business Overview Table 55. EverZom Exosome Manufacturing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. EverZom Exosome Manufacturing Service Product Portfolio Table 57. EverZom Recent Development Table 58. Lonza Company Information Table 59. Lonza Business Overview Table 60. Lonza Exosome Manufacturing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Lonza Exosome Manufacturing Service Product Portfolio Table 62. Lonza Recent Development Table 63. RoosterBio Company Information Table 64. RoosterBio Business Overview Table 65. RoosterBio Exosome Manufacturing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. RoosterBio Exosome Manufacturing Service Product Portfolio Table 67. RoosterBio Recent Development Table 68. SBI Company Information Table 69. SBI Business Overview Table 70. SBI Exosome Manufacturing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. SBI Exosome Manufacturing Service Product Portfolio Table 72. SBI Recent Development Table 73. Creative-Biolabs Company Information Table 74. Creative-Biolabs Business Overview Table 75. Creative-Biolabs Exosome Manufacturing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Creative-Biolabs Exosome Manufacturing Service Product Portfolio Table 77. Creative-Biolabs Recent Development Table 78. Esco Aster Company Information Table 79. Esco Aster Business Overview Table 80. Esco Aster Exosome Manufacturing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Esco Aster Exosome Manufacturing Service Product Portfolio Table 82. Esco Aster Recent Development Table 83. EXO Biologics Company Information Table 84. EXO Biologics Business Overview Table 85. EXO Biologics Exosome Manufacturing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. EXO Biologics Exosome Manufacturing Service Product Portfolio Table 87. EXO Biologics Recent Development Table 88. Eppendorf Company Information Table 89. Eppendorf Business Overview Table 90. Eppendorf Exosome Manufacturing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Eppendorf Exosome Manufacturing Service Product Portfolio Table 92. Eppendorf Recent Development Table 93. Aethlon Medical Company Information Table 94. Aethlon Medical Business Overview Table 95. Aethlon Medical Exosome Manufacturing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Aethlon Medical Exosome Manufacturing Service Product Portfolio Table 97. Aethlon Medical Recent Development Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Exosome Manufacturing Service Product Image Figure 2. Global Exosome Manufacturing Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Exosome Manufacturing Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Exosome Manufacturing Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Human Embryonic Kidney Cell-Derived Exosomes Image Figure 8. Bone Marrow Stem Cell-Derived Exosomes Image Figure 9. Immature Dendritic Cell-Derived Exosomes Image Figure 10. Milk-Derived Exosomes Image Figure 11. Red Blood Cell-Derived Exosomes Image Figure 12. Others Image Figure 13. Global Exosome Manufacturing Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Exosome Manufacturing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Exosome Manufacturing Service Sales Value Share by Type (2021-2032) Figure 16. Laboratory Image Figure 17. Pharmaceutical Companies Image Figure 18. Others Image Figure 19. Global Exosome Manufacturing Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Exosome Manufacturing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Exosome Manufacturing Service Sales Value Share by Application (2021-2032) Figure 22. Global Exosome Manufacturing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Exosome Manufacturing Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Exosome Manufacturing Service Sales Value (2021-2032) & (US$ Million) Figure 25. North America Exosome Manufacturing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Exosome Manufacturing Service Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Exosome Manufacturing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Exosome Manufacturing Service Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Exosome Manufacturing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Exosome Manufacturing Service Sales Value (2021-2032) & (US$ Million) Figure 31. South America Exosome Manufacturing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Exosome Manufacturing Service Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Exosome Manufacturing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Exosome Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Human Embryonic Kidney Cell-Derived Exosomes
  • Bone Marrow Stem Cell-Derived Exosomes
  • Immature Dendritic Cell-Derived Exosomes
  • Milk-Derived Exosomes
  • Red Blood Cell-Derived Exosomes
  • Others
Applications
  • Laboratory
  • Pharmaceutical Companies
  • Others
Companies covered
  • Guidon (Beijing) Pharmaceutical Technology
  • Cytoniche
  • EverZom
  • Lonza
  • RoosterBio
  • SBI
  • Creative-Biolabs
  • Esco Aster
  • EXO Biologics
  • Eppendorf
  • Aethlon Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Exosome Manufacturing Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Exosome Manufacturing Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Exosome Manufacturing Service Market Dynamics
  1. 2.1 Exosome Manufacturing Service Industry Trends
  2. 2.2 Exosome Manufacturing Service Industry Drivers
  3. 2.3 Exosome Manufacturing Service Industry Opportunities and Challenges
  4. 2.4 Exosome Manufacturing Service Industry Restraints
3 Exosome Manufacturing Service Market by Company
  1. 3.1 Global Exosome Manufacturing Service Company Revenue Ranking in 2025
  2. 3.2 Global Exosome Manufacturing Service Revenue by Company (2021-2026)
  3. 3.3 Global Exosome Manufacturing Service Company Ranking (2024-2026)
  4. 3.4 Global Exosome Manufacturing Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Exosome Manufacturing Service Company Product Type and Application
  6. 3.6 Global Exosome Manufacturing Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Exosome Manufacturing Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Exosome Manufacturing Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Exosome Manufacturing Service Market by Type
  1. 4.1 Exosome Manufacturing Service Type Introduction
  2. 4.1.1 Human Embryonic Kidney Cell-Derived Exosomes
  3. 4.1.2 Bone Marrow Stem Cell-Derived Exosomes
  4. 4.1.3 Immature Dendritic Cell-Derived Exosomes
  5. 4.1.4 Milk-Derived Exosomes
  6. 4.1.5 Red Blood Cell-Derived Exosomes
  7. 4.1.6 Others
  8. 4.2 Global Exosome Manufacturing Service Sales Value by Type
  9. 4.2.1 Global Exosome Manufacturing Service Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Exosome Manufacturing Service Sales Value by Type (2021-2032)
  11. 4.2.3 Global Exosome Manufacturing Service Sales Value Share by Type (2021-2032)
5 Exosome Manufacturing Service Market by Application
  1. 5.1 Exosome Manufacturing Service Application Introduction
  2. 5.1.1 Laboratory
  3. 5.1.2 Pharmaceutical Companies
  4. 5.1.3 Others
  5. 5.2 Global Exosome Manufacturing Service Sales Value by Application
  6. 5.2.1 Global Exosome Manufacturing Service Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Exosome Manufacturing Service Sales Value by Application (2021-2032)
  8. 5.2.3 Global Exosome Manufacturing Service Sales Value Share by Application (2021-2032)
6 Exosome Manufacturing Service Regional Value Analysis
  1. 6.1 Global Exosome Manufacturing Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Exosome Manufacturing Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Exosome Manufacturing Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Exosome Manufacturing Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Exosome Manufacturing Service Sales Value (2021-2032)
  7. 6.3.2 North America Exosome Manufacturing Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Exosome Manufacturing Service Sales Value (2021-2032)
  10. 6.4.2 Europe Exosome Manufacturing Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Exosome Manufacturing Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Exosome Manufacturing Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Exosome Manufacturing Service Sales Value (2021-2032)
  16. 6.6.2 South America Exosome Manufacturing Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Exosome Manufacturing Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Exosome Manufacturing Service Sales Value Share by Country, 2025 VS 2032
7 Exosome Manufacturing Service Country-level Value Analysis
  1. 7.1 Global Exosome Manufacturing Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Exosome Manufacturing Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Exosome Manufacturing Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Exosome Manufacturing Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Exosome Manufacturing Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Exosome Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Exosome Manufacturing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Guidon (Beijing) Pharmaceutical Technology
  2. 8.1.1 Guidon (Beijing) Pharmaceutical Technology Company Information
  3. 8.1.2 Guidon (Beijing) Pharmaceutical Technology Business Overview
  4. 8.1.3 Guidon (Beijing) Pharmaceutical Technology Exosome Manufacturing Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Guidon (Beijing) Pharmaceutical Technology Exosome Manufacturing Service Product Portfolio
  6. 8.1.5 Guidon (Beijing) Pharmaceutical Technology Recent Developments
  7. 8.2 Cytoniche
  8. 8.2.1 Cytoniche Company Information
  9. 8.2.2 Cytoniche Business Overview
  10. 8.2.3 Cytoniche Exosome Manufacturing Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Cytoniche Exosome Manufacturing Service Product Portfolio
  12. 8.2.5 Cytoniche Recent Developments
  13. 8.3 EverZom
  14. 8.3.1 EverZom Company Information
  15. 8.3.2 EverZom Business Overview
  16. 8.3.3 EverZom Exosome Manufacturing Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 EverZom Exosome Manufacturing Service Product Portfolio
  18. 8.3.5 EverZom Recent Developments
  19. 8.4 Lonza
  20. 8.4.1 Lonza Company Information
  21. 8.4.2 Lonza Business Overview
  22. 8.4.3 Lonza Exosome Manufacturing Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Lonza Exosome Manufacturing Service Product Portfolio
  24. 8.4.5 Lonza Recent Developments
  25. 8.5 RoosterBio
  26. 8.5.1 RoosterBio Company Information
  27. 8.5.2 RoosterBio Business Overview
  28. 8.5.3 RoosterBio Exosome Manufacturing Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 RoosterBio Exosome Manufacturing Service Product Portfolio
  30. 8.5.5 RoosterBio Recent Developments
  31. 8.6 SBI
  32. 8.6.1 SBI Company Information
  33. 8.6.2 SBI Business Overview
  34. 8.6.3 SBI Exosome Manufacturing Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 SBI Exosome Manufacturing Service Product Portfolio
  36. 8.6.5 SBI Recent Developments
  37. 8.7 Creative-Biolabs
  38. 8.7.1 Creative-Biolabs Company Information
  39. 8.7.2 Creative-Biolabs Business Overview
  40. 8.7.3 Creative-Biolabs Exosome Manufacturing Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Creative-Biolabs Exosome Manufacturing Service Product Portfolio
  42. 8.7.5 Creative-Biolabs Recent Developments
  43. 8.8 Esco Aster
  44. 8.8.1 Esco Aster Company Information
  45. 8.8.2 Esco Aster Business Overview
  46. 8.8.3 Esco Aster Exosome Manufacturing Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Esco Aster Exosome Manufacturing Service Product Portfolio
  48. 8.8.5 Esco Aster Recent Developments
  49. 8.9 EXO Biologics
  50. 8.9.1 EXO Biologics Company Information
  51. 8.9.2 EXO Biologics Business Overview
  52. 8.9.3 EXO Biologics Exosome Manufacturing Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 EXO Biologics Exosome Manufacturing Service Product Portfolio
  54. 8.9.5 EXO Biologics Recent Developments
  55. 8.10 Eppendorf
  56. 8.10.1 Eppendorf Company Information
  57. 8.10.2 Eppendorf Business Overview
  58. 8.10.3 Eppendorf Exosome Manufacturing Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Eppendorf Exosome Manufacturing Service Product Portfolio
  60. 8.10.5 Eppendorf Recent Developments
  61. 8.11 Aethlon Medical
  62. 8.11.1 Aethlon Medical Company Information
  63. 8.11.2 Aethlon Medical Business Overview
  64. 8.11.3 Aethlon Medical Exosome Manufacturing Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Aethlon Medical Exosome Manufacturing Service Product Portfolio
  66. 8.11.5 Aethlon Medical Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst